Bregtje Kamphuis

Principal Consultant

Offices: Netherlands
Email: Bregtje.Kamphuis@technopolis-group.com

Bregtje Kamphuis is a Principal Consultant in Health & Life Sciences at Technopolis. Bregtje’s main areas of expertise are pharmaceutical pricing and reimbursement policies, access to medicines, comparative health policy, health systems, sustainable healthcare financing, and evidence-based policy analysis. She is experienced with various methods, including structured and non-structured interviews, surveys, Delphi panels, case studies, desk research and systematic/comprehensive literature reviews.

Prior to Technopolis, Bregtje worked at the London School of Economics and Political Science for 10 years. She was an Associate Director in Health Policy at the Medical Technology Research Group (MTRG) at the London School of Economics and Political Science for four years. Her research focus was on pharmaceutical pricing and reimbursement policies and access to medicines, but she also works on projects looking at appropriateness and quality of care in specific disease areas such as asthma, autism and migraine. In her role at the MTRG, she was responsible for conducting research, drafting reports and journal articles, and responsible for the design, management, and delivery of research outputs for a variety of international and industry clients. Prior to joining the MTRG, she was a Project Manager and Researcher at LSE Consulting for six years, managing projects and conducting research in social policy for international organizations, European bodies, governments, and private clients.

Bregtje has an MSc in International Health Policy (LSE), an MSc in Law, Anthropology and Society (LSE), and a BA in Liberal Arts from the University College of Utrecht. She is fluent in English and Dutch.

Recent and relevant assignments include:

  • Ensuring patient access to medicines in Austria and in the EU by improving the pharmaceutical value chain. DG Reform.

Previous relevant studies include:

  • ‘Access to medicines: underlying reasons for access barriers and recommendations for improving access to new therapies, with a focus on HIV/AIDS and oncology’. (2022). MSD. Lead researcher and project manager.
  • ‘Development of policies to increase headroom for innovation in Saudi Arabia and Egypt, with a focus on policies for innovative and generic medicines’. (2022). Pharmaceutical Research and Manufacturers of America. Lead researcher and project manager.
  • ‘Towards better outcomes in autism spectrum disorder (ASD) by addressing policy change’. (2022). Confidential client. Lead researcher and project manager.
  • ‘The role of virtual health care and the pharmaceutical sector in improving population health’. (2021). Sanofi. Lead researcher and project manager; workshop panel chair.
  • ‘Severe Asthma Healthcare Policy Audits’. (2021). AstraZeneca. Lead researcher and project manager; lead on infographic content.
  • ‘Latin America healthcare system overview: A comparative analysis of fiscal space in healthcare’. (2019). F. Hoffman La-Roche. Researcher; lead on infographic content.
  • ‘Pricing and reimbursement in the Middle East and North Africa region: A mapping of the current landscape and recommendations for the way forward’. (2018). Pharmaceutical Research and Manufacturers of America. Researcher.
  • ‘The use of Real-World Evidence – Opportunities for Europe’. (2019). F. Hoffman LaRoche. Role: Researcher; lead author.
  • ‘Mapping of the Regulatory Environments in the Pharmaceutical Sector in SEMED’ (2018). EBRD. Researcher.
  • ‘The impact of migraine on the workplace in 16 European countries’. (2018). Confidential client. Project manager & lead researcher.
  • ‘Social Situation Monitor’ (2018). DG Employment, Social Affairs. Project manager & core team member.
  • ‘Ex-ante Study of the EU-Australia and EU-New Zealand Trade and Investment Agreements’. (2017). DG Trade. Researcher.
  • ‘Study on EU funds for migration policies: analysis of efficiency of current policies and delineating best practice for the future’. (2015). European Parliament, Project manager and researcher.
  • ‘The Place of Local and Regional Self-Government in Eastern Partnership Policy-Making and Delivery’. (2015). EU Committee of the Regions. Project Manager and Researcher.
  • ‘Baseline survey on “Regional Support for Inclusive Education”’. (2015). Council of Europe. Core research team member.
  • ‘Social Inclusion Monitor Survey: Survey across all European countries on policies in education, health, labour markets, poverty, social cohesion, and social welfare’ (2014). Bertelsmann Foundation. Project manager and core team researcher.
  • ‘Higher Education Entrance Qualifications and Exams in Europe: A Comparison’. (2014). European Parliament. Researcher.

Publications

Journal articles

  • Kamphuis, B.W., Kanavos P. Sixty-five years of rate of return regulation in the United Kingdom: Merging health with industrial policy objectives through the Pharmaceutical Price Regulation Scheme. (Submitted, under review).
  • Kamphuis, B.W. Blogpost: Generic pharmaceutical policies in the MENA region. GaBI Generics and Biosimilars Initiative. Available at: https://www.gabionline.net/generics/research/generic-pharmaceutical-policies-in-the-mena-region
  • Kamphuis, B.W., Kanavos, P. (2021) Assessing the design and implementation of policies for generic pharmaceuticals across efficiency, cost-effectiveness and generic penetration in the MENA region. Health Policy OPEN Volume 2, December 2021, 100045.
  • Kanavos P, Kamphuis BW, Fontrier AM, Colville Parkin G, Saleh S, Akhras KS. Pricing of in-patent pharmaceuticals in the Middle East and North Africa: Is external reference pricing implemented optimally? Health Policy. 2020 Dec;124(12):1297-1309. doi: 10.1016/j.healthpol.2020.07.017. Epub 2020 Aug 14. PMID: 32962876.

Policy reports

  • Kamphuis, B.W., Fontrier, A-M, Haig, M., Politopoulou, K., Salyga, H., Gentilini, A., and Kanavos, P. (2022). Development of policies to increase headroom for innovation in Egypt and the Kingdom of Saudi Arabia. London School of Economics and Political Science.
  • Kamphuis, B.W., Fontrier, A-M., Efthymiadou, O., Gill, J., Salyga, H. and Kanavos, P. (2021). Access to medicines in Europe: Delays and challenges for timely patient access. London School of Economics and Political Science.
  • Kamphuis, B.W., Gill, J., Vogelzang, M., Haig, M. and Kanavos, P. (2021). The role of virtual health care and the pharmaceutical sector in improving population health. London School of Economics and Political Science. · Efthymiadou, O., Kamphuis, B.W., Tzouma, V., Kanavos, P. (2021). Treatment gaps in severe asthma across nine OECD countries and recommendations for addressing them: An international survey of clinicians. London School of Economics and Political Science.
  • Kamphuis, B.W., Efthymiadou, O. Tzouma, V., Kanavos, P. (2021). Severe asthma care and treatment: Indicators and data for performance management across ten countries. London School of Economics and Political Science.
  • Kanavos, P.; Colville, G.; Kamphuis, B.W.; Gill, J. (2019). Latin America healthcare system overview: A comparative analysis of fiscal space in healthcare. London School of Economics and Political Science.
  • Kamphuis, B.W. et al. (2019). Paper V: Policy Challenges around Real World Evidence Adoption in Europe. London School of Economics and Political Science.
  • Kanavos, P.; Saleh, S.; Kamphuis, B.W.; Arnaout, N; McClain, K. (2018). Mapping of the Regulatory Environments in the Pharmaceutical Sector in SEMED. European Bank for Reconstruction and Development.
  • Kanavos, P.; Tzouma, V.; Fontrier, A-M.; Kamphuis, B.W.; Colville, G.; Saleh, S. (2018). Pricing and reimbursement in the Middle East and North Africa region: A mapping of the current landscape and recommendations for the way forward. PhRMA. London School of Economics and Political Science.
  • Kanavos, P., Colville, G., Kamphuis, B.W., Gill, J. (2018). Latin America healthcare system overview: A comparative analysis of fiscal space in healthcare. London School of Economics and Political Science.
  • Bartlett, W.; Gordon, C.; Kamphuis, B.W. (2015) Evaluation of the EU Framework for National Roma Integration Strategies. European Parliament. Available at: http://www.europarl.europa.eu/thinktank/en/document.html?reference=IPOL_STU(2015)536485
  • Hausemer, P.; Todaro, L.; Kamphuis, B.W. et al (2015). EU funds for migration policies: Analysis of Efficiency and best practice for the future. European Parliament. Available at: http://www.europarl.europa.eu/RegData/etudes/STUD/2015/552298/IPOL_STU(2015)552298_EN.pdf
  • Bartlett, W., Durazzi, N., Kamphuis, B.W. et al. (2014), Cross-Beneficiary Report: Regional Support for Inclusive Education. Council of Europe and the European Union. Available at: http://pjp-eu.coe.int/documents/1473702/2308705/Baseline+survey-Cross-Beneficiary+and+7+Beneficiaries+Reports-final.pdf/02491b98-4f08-48de-b190-6e8387ff333c
  • Hoareau, C, Durazzi, N., Frearson, M., Corbett, A., Kamphuis, B.W. (2014), Higher Education Entrance Qualification and Exams in Europe: A Comparison. European Parliament.
  • Available at: http://www.europarl.europa.eu/RegData/etudes/etudes/join/2014/529057/IPOL-CULT_ET(2014)529057_EN.pdf
  • Brennan, J., Broek, S.D., Durazzi, N., Kamphuis, B.W., Ranga, M. and Ryan, S. (2014) Study on Innovation in Higher Education. European Commission. Available at: http://ec.europa.eu/education/tools/docs/study-innovation-he_en.pdf.